IP Library Assignment 070664/0235
Patent Assignment
Reel/Frame 070664/0235

Change of Address

Recorded: 2025-03-17 Pages: 10
Assignor
Assignee
OMEGA PHARMA INNOVATION & DEVELOPMENT NV
ZUIDERPOORT OFFICE PARK, ATRIUM B, GASTON CROMMENLAAN 6, BOX 606, GENT, 9050, BELGIUM
Covered Properties (2)
Formulation
Patent: 9,107,846 →
Application: 12/666,609 →
Publication: US 2010/0183709
Buccal Drug Delivery
Patent: 8,858,984 →
Application: 14/071,740 →
Publication: US 2014/0054826
Related Assignments (5)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Apr 10, 2019
From: GELMEDIC HOLDING APS
To: BDD DEVELOPMENT APS
Reel/Frame 048841/0314 →
Assignment of Assignor's Interest Mar 23, 2021
From: BDD DEVELOPMENT APS
To: OMEGA PHARMA INNOVATION & DEVELOPMENT NV
Reel/Frame 055679/0476 →
Security Agreement Jun 13, 2022
From: L. PERRIGO COMPANY; PBM NUTRITIONALS, LLC; PERRIGO DIABETES CARE, LLC; RANIR, LLC
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 060362/0887 →
Security Agreement Aug 3, 2022
From: OMEGA PHARMA INNOVATION & DEVELOPMENT NV
To: JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT
Reel/Frame 061069/0513 →
Assignment of Assignor's Interest Sep 14, 2025
From: OMEGA PHARMA INNOVATION & DEVELOPMENT NV
To: PERRIGO PHARMA INTERNATIONAL DAC
Reel/Frame 072247/0287 →